This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.
Adipotide
Peptide for Research
/WHAT_IT_IS
Adipotide, also known as FTPP (Fat Targeted Proapoptotic Peptide), is an experimental peptide designed to induce targeted apoptosis of fat cells, potentially resulting in rapid reduction of body fat in animal studies.
/USAGE
Primarily used in research settings to investigate its effects on body weight reduction, fat loss, and metabolic health. Not approved for human use.
/MECHANISM_OF_ACTION
Adipotide targets specific proteins on the surface of fat cell blood vessels (Prohibitin and ANXA2), causing apoptosis (cell death) in the blood vessels supplying white adipose tissue. This leads to fat cell death and subsequent reduction of fat mass.
Reported Benefits
- +Rapid fat loss observed in animal studies
- +Reduces white adipose tissue
- +Potential metabolic improvements (e.g., insulin sensitivity)
- +Non-stimulant fat loss mechanism
Reported Side Effects
- −Dehydration
- −Mild to moderate kidney stress (noted in primate studies)
- −Electrolyte imbalance
- −Potential for nausea, lethargy, and other systemic effects
/STACKED_WITH
/RESEARCH_NOTES
Not for human consumption. Most studies have been in mice and primates; results in humans are unknown. Reversible renal side effects have been observed at higher doses in animal studies. Should only be handled by qualified professionals.
/REFERENCE
https://en.wikipedia.org/wiki/Adipotide;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575885//RELATED
Browse all 89 in the app.
MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.